Atreya R (2023)
Publication Type: Journal article
Publication year: 2023
Book Volume: 18
Pages Range: 440-447
Journal Issue: 6
DOI: 10.1007/s11377-023-00744-w
Background: Although the introduction of targeted therapies has led to a significant improvement in the care of patients with inflammatory bowel diseases (IBD), only a subgroup of the treated patients benefit from the initiated treatments. Furthermore, the individual disease course in patients with IBD is often unclear. Objectives: To what extent are currently available predictive biomarkers able to predict treatment response and disease progression in IBD patients? Materials and methods: Evaluation of available studies that have characterized potential biomarkers to evaluate treatment response and disease progression. Results: Substantial progress has been made in various areas of biomarker studies to identify relevant biomarkers, yet their use in clinical practice is still not foreseeable. Conclusion: Potential biomarkers must be validated in independent cohorts with comparable endpoints before they can be used in daily clinical practice.
APA:
Atreya, R. (2023). Prediction of disease progression and treatment success: Importance of individualized treatment approaches Prädiktion von Krankheitsverlauf und Therapieerfolg: Stellenwert individualisierter Therapieansätze. Die Gastroenterologie, 18(6), 440-447. https://doi.org/10.1007/s11377-023-00744-w
MLA:
Atreya, Raja. "Prediction of disease progression and treatment success: Importance of individualized treatment approaches Prädiktion von Krankheitsverlauf und Therapieerfolg: Stellenwert individualisierter Therapieansätze." Die Gastroenterologie 18.6 (2023): 440-447.
BibTeX: Download